ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

SciELO - Brasil - Diretriz Brasileira de Cardio-oncologia – 2020 Diretriz Brasileira de Cardio-oncologia
– 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos Lista temática de …

The considerable progress made in the field of cancer treatment has led to a dramatic
improvement in the prognosis of patients with cancer. However, toxicities resulting from …

Diretriz Brasileira de Cardio-oncologia–2020 O relatório abaixo lista as declarações de
interesse conforme relatadas à SBC pelos especialistas durante o período de …

Background In patients with active cancer and atrial fibrillation (AF) anticoagulation,
thrombotic and bleeding risk still entail uncertainty. Aim We explored the results of an …

Background Atrial fibrillation (AF) is a common cardiovascular complication affecting
patients with cancer, but management strategies are not well established. Objectives The …

Abstract Background Implementation of the Atrial fibrillation Better Care (ABC) pathway is
recommended by guidelines on atrial fibrillation (AF), but the impact of adherence to ABC …

Both cancer treatment and survival have significantly improved, but these advances have
highlighted the deleterious effects of vascular complications associated with anticancer …

Cancer patients have a higher risk of atrial fibrillation (AF) than general population, the
pathophysiology mechanisms involves the pro inflammatory status of immune system in …

Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with an
increased morbidity and mortality. There is clinical evidence that an increasing number of …